SS
YMAB

SBI Securities’s Y-mAbs Therapeutics YMAB Stock Holding History

SBI Securities’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$72 – 4329
2025
Q2 		$72 Hold
16
– – ﹤0.01% 3632
2025
Q1 		$71 Hold
16
– – ﹤0.01% 3556
2024
Q4 		$125 Buy
+16
New +$195 ﹤0.01% 3391

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities's YMAB Position: Q3 2025 in Review

SBI Securities sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 16 shares — an estimated $72 sold.

SBI Securities first reported a position in YMAB in Q4 2024 and held it in 3 quarters. The position peaked at $125 in Q4 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • SBI Securities reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • SBI Securities sold 16 Y-mAbs Therapeutics shares in Q3 2025, an estimated $72.
  • SBI Securities first reported a position in Y-mAbs Therapeutics in Q4 2024 and held it in 3 quarters.
  • SBI Securities's Y-mAbs Therapeutics position peaked at $125 in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.